- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-18-0084548

About Pehal Life Sciences Private Limited
Data last updated:
Pehal Life Sciences Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 June 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2016PTC282589. Its GSTIN is 27AAICP6545N1ZQ (Maharashtra).
The company has an authorised share capital of ₹4.17 Cr and a paid-up capital of ₹17.4 Lakh. It is led by directors Sanket Dilipraj Bhosale and Ashwini Chandrahas Shetty.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Off517 B Swastik Disha Corporate Park, Mumbai, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹8.66 Cr, a decline of 33% compared to the previous year. For the same year it recorded a net loss of ₹3.04 Cr (net margin -35.1%) and EBITDA of -₹2.39 Cr (EBITDA margin -27.6%). Revenue has grown at a compounded annual rate (CAGR) of 85% over three years and 75% over five years.
The company has about 8 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹1.93 Cr and satisfied charges of ₹1.93 Cr on record. Court records list 2 cases involving the company, including 2 filed against it.
Pehal Life Sciences Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0084548). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pehal.info.
Company details
Recognitions & Rankings of Pehal Life Sciences
Contact details
Pehal Life Sciences Private Limited's registered office is in Mumbai, Maharashtra. Its website is pehal.info. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Registered AddressOff517 B Swastik Disha Corporate Park Kohinoor, Compd L B S Marg Ghatkopar(W) Opp Shreyas Cinema, Mumbai, Maharashtra, India – 400086
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Pehal Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Pehal Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Pehal Life Sciences Private Limited, buy the company report.
Financials of Pehal Life Sciences Private Limited
FY 2025 filings availablePehal Life Sciences Private Limited reported revenue of ₹8.66 Cr (down 33% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 33% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 75%. EBITDA fell 35% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.39 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.04 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -27.6% | ||||
| Net Profit Margin | -35.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Pehal Life Sciences Private Limited, buy the company report.
Board of directors of Pehal Life Sciences Private Limited
Pehal Life Sciences has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanket Dilipraj Bhosale | Director | 06 Sep 2023 | 3 Years 2 Months | Current |
| Ashwini Chandrahas Shetty | Director | 15 Jun 2023 | 3 Years 5 Months | Current |
Peer comparison
Pehal Life Sciences Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Atilus Pharma Private Limited | ₹8.68 Cr (FY 2025) | -20.0% | Mumbai, Maharashtra, India | |||
| Pehal Life Sciences Private Limitedthis company | ₹8.66 Cr (FY 2024) | -₹3.04 Cr | -35.1% | -33.0% | 8 | Mumbai, Maharashtra, India |
| Waxsen Lifescience Private Limited | ₹8.64 Cr (FY 2019) | -50.0% | Mumbai, Maharashtra, India | |||
| Srikar Chem & Pharma India Private Limited | ₹8.6 Cr (FY 2024) | -11.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Pehal Life Sciences Private Limited, buy the company report.
Auditor
Pehal Life Sciences Private Limited is audited by PRASHANT MITTAL AND ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PRASHANT MITTAL AND ASSOCIATES | FY 2022 | 126763W |
Shareholding
The shareholding of Pehal Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Pehal Life Sciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Jun 2022 | 100591407 | Others | ₹1.93 Cr | Satisfied |
To see the full charge records of Pehal Life Sciences Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Pehal Life Sciences Private Limited has 2 court cases on record: 2 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
| NCLT | 1 | 1 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, Mumbai | Insolvency matter | Filed against the company by an individual | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons Private cases SS) | Filed against the company by an individual | Disposed |
To see the full case history of Pehal Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Pehal Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Pehal Life Sciences Private Limited has a workforce of 8 employees on its EPFO records as of Mar 2024, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2023-24 | 8 |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2018-19 |
To see the full employee and EPFO history of Pehal Life Sciences Private Limited, buy the company report.
GST
Pehal Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICP6545N1ZQ | Maharashtra | Active | 04 Jun 2018 |
To see the full GST registrations and return filing status of Pehal Life Sciences Private Limited, buy the company report.
Recent activity
Pehal Life Sciences Private Limited has 6 board changes on record since 2021: 4 appointments and 2 cessations. The latest: Puran Singh was appointed as Director on 01 Mar 2025.
Frequently asked questions
Pehal Life Sciences is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 June 2016 (10+ years old) and is registered under CIN U74999MH2016PTC282589.
Pehal Life Sciences has 2 current directors:
- Sanket Dilipraj Bhosale - Director
- Ashwini Chandrahas Shetty - Director
The latest financial statements of Pehal Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Pehal Life Sciences is 27AAICP6545N1ZQ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Pehal Life Sciences is U74999MH2016PTC282589. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pehal Life Sciences has 2 court cases on record: 2 filed against it. Most are in the district courts.
Pehal Life Sciences was incorporated on 20 June 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Pehal Life Sciences by revenue are Atilus Pharma Private Limited, Waxsen Lifescience Private Limited, Srikar Chem & Pharma India Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Puran Singh was appointed as Director on 01 Mar 2025. Rekha Shah Sanjay ceased to be Director on 01 Mar 2025. Smita Sachin Bamne was appointed as Director on 01 Mar 2025. Pehal Life Sciences has 6 board changes on record in total.
Yes, Pehal Life Sciences is registered as a small enterprise under Udyam registration (number: UDYAM-MH-18-0084548).
Pehal Life Sciences can be reached through the website pehal.info. Its registered office is in Mumbai, Maharashtra, India.

